Could Recreating a Rare Mutation Grant Almost Universal Virus Immunity For Days?

Columbia University’s Dusan Bogunovic has identified a rare genetic mutation that confers antiviral superpowers to individuals by enhancing their immune system’s response, which he is now leveraging to develop a universal antiviral therapy. His experimental approach, modeled after COVID mRNA vaccines, shows promise in protecting against various viruses by temporarily activating the immune response with minimal inflammation.

Want More Context? 🔎